Home / Health / Japanese Pharma Urges Halt to Tavneos Drug After Deaths
Japanese Pharma Urges Halt to Tavneos Drug After Deaths
3 Jun
Summary
- Kissei Pharmaceutical is advising doctors to cease Tavneos prescriptions.
- Twenty fatalities in Japan are associated with the drug Tavneos.
- Tavneos is facing worldwide regulatory attention and scrutiny.
Kissei Pharmaceutical, the distributor of Amgen Inc.'s drug Tavneos in Japan, has issued a strong recommendation for healthcare professionals to halt its prescription. This critical advice follows the concerning news that twenty patients in Japan have died after receiving treatment with Tavneos.
The drug is now under intense scrutiny from health regulators across the globe. Kissei's recommendation adds significant pressure on Amgen Inc. as international health authorities review the safety and efficacy of Tavneos.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
